Moderna mRNA Vaccine Tech Patents Invalidated by Tribunal (1)

Pfizer Inc. and BioNTech SE convinced an administrative tribunal to throw out portions of two patents Moderna Inc. asserted against the companies in litigation over their competing Covid-19 vaccines.

The Patent Trial and Appeal Board, part of the US Patent and Trademark Office, invalidated the challenged claims in US Patent Nos. 10,933,127 and 10,702,600, according to Wednesday docket entries in the tribunal’s case-tracking system. The decisions in each docket—both titled “Determining All Challenged Claims Unpatentable"—are sealed.

Moderna sued BioNTech and Pfizer in the US District Court for the District of Massachusetts in August 2022 alleging their Comirnaty shot infringes ...